RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kamal Masaki to Adrenergic beta-Antagonists

Back to Details
This is a "connection" page, showing publications Kamal Masaki has written about Adrenergic beta-Antagonists.
Kamal Masaki
Connection Strength
0.135
Adrenergic beta-Antagonists
  1. Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR. Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013 Sep 03; 81(10):888-95.
    View in: PubMed
    Score: 0.113
  2. Robinson JG, Wallace R, Safford MM, Pettinger M, Cochrane B, Ko MG, O'Sullivan MJ, Masaki K, Petrovich H. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. J Clin Lipidol. 2010 Jan-Feb; 4(1):36-45.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support